Compare ALT & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALT | CAL |
|---|---|---|
| Founded | 1997 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 450.1M |
| IPO Year | N/A | N/A |
| Metric | ALT | CAL |
|---|---|---|
| Price | $3.61 | $12.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $16.33 | $14.00 |
| AVG Volume (30 Days) | ★ 4.8M | 1.1M |
| Earning Date | 11-06-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $20,000.00 | ★ $2,702,018,000.00 |
| Revenue This Year | N/A | $2.22 |
| Revenue Next Year | N/A | $3.67 |
| P/E Ratio | ★ N/A | $19.69 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $9.54 |
| 52 Week High | $7.83 | $23.82 |
| Indicator | ALT | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 43.97 |
| Support Level | $3.83 | $12.62 |
| Resistance Level | $5.37 | $13.42 |
| Average True Range (ATR) | 0.32 | 0.57 |
| MACD | -0.18 | -0.14 |
| Stochastic Oscillator | 2.39 | 5.99 |
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.